Question 1

How many shares of CYTK does Candriam S.C.A. own?

Accepted Answer

As of 2026-Q2, Candriam S.C.A. holds 443,066 shares of CYTK (CYTOKINETICS INC).

Question 2

What is Candriam S.C.A.'s CYTK position worth?

Accepted Answer

As of 2026-Q2, Candriam S.C.A.'s CYTK position is worth $37.7M.

Question 3

Is Candriam S.C.A. buying or selling CYTK?

Accepted Answer

In 2026-Q2, Candriam S.C.A. increased their CYTK position (+32.2% change in shares).

Question 4

When did Candriam S.C.A. first buy CYTK?

Accepted Answer

Based on available 13F filings, Candriam S.C.A. first reported a position in CYTK in 2024-Q3. They have held the position across 23 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	443,066	+32.2%	$37.7M	0.2%	$85.19	44
2026-Q1	Increased	335,208	+128.6%	$22.1M	0.1%	$60.72	55
2025-Q4	New	146,631	—	$9.3M	0.0%	$61.37	38
2025-Q2	Exited	0	-100.0%	$0	0.0%	$33.16	0
2025-Q1	Decreased	145,191	-14.9%	$5.8M	0.0%	$43.19	0
2024-Q4	Decreased	170,560	-4.8%	$8M	0.0%	$47.15	0
2024-Q3	Unchanged	179,200	0.0%	$9.5M	0.1%	$52.34	0